FreeStyle Libre flash glucose monitoring system use in insulin-treated patients undergoing dialysis: a pilot study

Abbott Diabetes Care Ltd0 个研究点目标入组 25 人开始时间: 2018年12月10日最近更新: 2019年7月29日

试验速览

暂无简介。

•1. Aged 18 years or over
•2. Type 1 or type 2 diabetes
•3. Requiring insulin therapy
•4. Willing and able to test their blood glucose levels via fingerprick at least four times a day using the FreeStyle Libre System
•5. In the investigator’s opinion, technically capable of using the study device
•6. On stable haemodialysis (i.e. treatment using dialysis has been in progress for a minimum of 90 days)

•1. Concomitant disease or condition that may compromise patient safety including and not limited to cystic fibrosis, severe mental illness, known or suspected eating disorder or any uncontrolled long term medical condition
•2. Currently prescribed oral steroid therapy for any acute or chronic condition
•3. Female participant known to be pregnant
•4. Have a pacemaker or any other neurostimulators
•5. Known (or suspected) allergy to medical grade adhesives
•6. In the investigator’s opinion, is unsuitable to participate due to any other reason

发起方

Abbott Diabetes Care Ltd